CSF2 and cancer: The levels of MDSCs, granulocyte-macrophage colony-stimulating factor (GM-CSF), soluble vascular cell adhesion molecule 1 (sVCAM-1), IL-8, and IL-1 receptor against are shown to be significantly elevated in cancer patients suffering from VTE post immune checkpoint inhibitor challenge [147].